Latest Updates on CVNA
-
Options Double Your Money in a Few Months with These “Growth Stock” Options Plays
Shah Gilani picks out two options trades off of the dip in growth stocks that are primed to double an investor's return in just a few months. Read more » -
Trading Strategies As America Reopens, Explosive Pent-Up Demand Will Benefit These Companies First
After the long coronavirus shutdowns, 35 states are now reopening or about to reopen. While the U.S. has shed about 26 million jobs over the pasts two months, the hope is that companies rehire the employees they've had to let go, and that … Read more » -
stocks Markets Live Recap: Stocks Rise Despite 3.17 Million More Unemployment Claims
The U.S. weekly jobless claims number increased another 3.17 million people (versus the 3.05 million expected by economists) today. That brings the total to 33.5 million Americans unemployed over the last seven weeks. Stocks shook … Read more » -
stocks Markets Live Recap: Why Oil Prices and Stocks Both Surged Today
The biggest news of the day was the 20% pop for oil prices. They surged thanks to optimism around production cuts. There are also expectations from analysts that demand for the commodity will increase as some economies attempt to … Read more » -
Dow Jones Expect the Dow Jones Industrial Average to Stay Flat Today Thanks to China
Today's Dow Jones Industrial Average will be largely flat after revived tensions in the U.S.-China trade talks. Read more » -
IPOs Recent IPO Movers of the Week (June 12-16, 2017)
Here's a look at the biggest recent IPO movers for the week of June 12-16, 2017. Carvana Co. led the way for the second straight week, and Impinj Inc. jumped on Amazon's big acquisition. ObsEva SA made the losers list again in spite of positive … Read more » -
IPOs Recent IPO Movers of the Week (June 5-9, 2017)
Here's a look at the biggest recent IPO movers for the week of June 5-9, 2017. Carvana led the way with an almost 40% jump, and At Home Group defied the "Retail Ice Age" with a 20% jump. ObsEva and Fulgent Genetics were the big losers with 20%-plus … Read more »
